Atopic Eczema

被引：0
作者：
Wollenberg, A. [1 ]
Biedermann, T. [2 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Klin Dermatol & Allergol, Frauenlobstr 9-11, D-80337 Munich, Germany
[2] Tech Univ Munich, Klin & Poliklin Dermatol & Allergol, Biedersteinerstr 29, D-80802 Munich, Germany
来源：
HAUTARZT | 2018年 / 69卷 / 03期
关键词：
DERMATITIS; GUIDELINES;
D O I：
10.1007/s00105-018-4140-7
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Atopic dermatitis affects roughly 20% of children and 3% of adults in Germany and other industrial countries, with an increasing prevalence. Its causality has still not been conclusively clarified but a typeaEuro2 TaEurohelper cell mediated immunity reaction (type 2 immunity) dominates cutaneous inflammation. In the quest for the underlying pathogenic mechanisms and the development of improved prevention and treatment options, attention is also increasingly being paid to the influence of microbial colonization. This is facilitated by the rapid development of microbial analysis by sequencing. An increasing number of studies have shown that there is a link between disorders of the skin microbiome and the occurrence of atopic eczema and some also point towards the intestinal microbiome. In particular, a loss of diversity regarding the composition of the microbiome has been observed.
引用
收藏
页码：190 / 190
页数：1
相关论文
共 10 条
  • [1] Heratizadeh A, 2018, HAUTARZT
  • [2] Knop M, 2018, HAUTARZT
  • [3] Koberle M, 2018, HAUTARZT
  • [4] Meyer NH, 2018, HAUTARZT
  • [5] Guidelines for treatment of atopic eczema (atopic dermatitis) Part II
    Ring, J.
    Alomar, A.
    Bieber, T.
    Deleuran, M.
    Fink-Wagner, A.
    Gelmetti, C.
    Gieler, U.
    Lipozencic, J.
    Luger, T.
    Oranje, A. P.
    Schaefer, T.
    Schwennesen, T.
    Seidenari, S.
    Simon, D.
    Staender, S.
    Stingl, G.
    Szalai, S.
    Szepietowski, J. C.
    Taieb, A.
    Werfel, T.
    Wollenberg, A.
    Darsow, U.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (09) : 1176 - 1193
  • [6] Guidelines for treatment of atopic eczema (atopic dermatitis) Part I
    Ring, J.
    Alomar, A.
    Bieber, T.
    Deleuran, M.
    Fink-Wagner, A.
    Gelmetti, C.
    Gieler, U.
    Lipozencic, J.
    Luger, T.
    Oranje, A. P.
    Schaefer, T.
    Schwennesen, T.
    Seidenari, S.
    Simon, D.
    Staender, S.
    Stingl, G.
    Szalai, S.
    Szepietowski, J. C.
    Taieb, A.
    Werfel, T.
    Wollenberg, A.
    Darsow, U.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (08) : 1045 - 1060
  • [7] Scheerer C, 2018, HAUTARZT
  • [8] Werfel T, 2018, HAUTARZT
  • [9] ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients
    Wollenberg, A.
    Oranje, A.
    Deleuran, M.
    Simon, D.
    Szalai, Z.
    Kunz, B.
    Svensson, A.
    Barbarot, S.
    von Kobyletzki, L.
    Taieb, A.
    de Bruin-Weller, M.
    Werfel, T.
    Trzeciak, M.
    Vestergard, C.
    Ring, J.
    Darsow, U.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (05) : 729 - 747
  • [10] Long Term Treatment Concepts and Proactive Therapy for Atopic Eczema
    Wollenberg, Andreas
    Ehmann, Laura Maximiliane
    [J]. ANNALS OF DERMATOLOGY, 2012, 24 (03) : 253 - 260
1